VEGFA and Alzheimer disease: Following IV injection of Ab‐TP‐MDNPs twice weekly for 2 weeks (Figure4A), the expression of VEGF observed in AD mouse brains was reduced by 18% compared to the vehicle‐treated group (Figure 4B).